Singer Capital Markets appointed as Joint Broker to Poolbeg Pharma plc
Singer Capital Markets is delighted to announce its appointment as Joint Broker to Poolbeg Pharma plc with immediate effect.
About Poolbeg Pharma plc
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which aims to develop multiple products faster and more cost effectively than the conventional biotech model. The Company is targeting the growing infectious disease market, which is a key area of Singer Capital Markets’ research focus. In the wake of the COVID-19 pandemic, infectious disease has become one of the fastest growing pharma markets and is expected to exceed $250bn by 2025.
Market Cap: £24 million*
Website: Click here
*As at 29/07/2022